This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Mcgill University, Polyvalor, Limited Partnership, Universitéde Montreal. Active years: 1998-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1998-2022
Title: The Innovations of Anne-Marie Mes-Masson
Introduction
Anne-Marie Mes-Masson is a notable inventor based in Dollard-des-Ormeaux, Canada. She has made significant contributions to the field of medical diagnostics and sample preparation, holding a total of 3 patents. Her work has advanced methodologies that are crucial for cancer diagnosis and sample analysis.
Latest Patents
Among her latest patents is a method for preparing a medium-embedded-sample-block. This innovative method involves obtaining a frame with multiple sample wells arranged in a two-dimensional array. The process includes placing embedding medium in the wells to immerse the samples, allowing the medium to form a block, and then separating the frame to obtain the final product. Another significant patent focuses on diagnosing ovarian cancer. This method includes providing a biological sample from a subject and detecting the expression levels of specific markers, FGF-2 and CA125, which are crucial for effective diagnosis.
Career Highlights
Anne-Marie has worked with esteemed institutions such as Université de Montréal and Polyvalor, Limited Partnership. Her experience in these organizations has allowed her to collaborate on various innovative projects that have contributed to her success as an inventor.
Collaborations
Some of her notable coworkers include Diane Provencher and Thomas Gervais. Their collaboration has likely enriched the research environment and fostered innovative ideas in their respective fields.
Conclusion
Anne-Marie Mes-Masson exemplifies the spirit of innovation in the medical field through her patents and collaborative efforts. Her work continues to impact the way biological samples are prepared and analyzed, particularly in the context of cancer diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile